MAPT and Alzheimer disease: More modest associations with tau PET positivity were found for APOE ε4 status (temporal meta-ROI only) and lower AD-signature cortical thickness (temporal meta-ROI and Braak V-VI regions), and sex and global WMH volumes did not impact tau PET status in Aβ-positive AD dementia.